NEW DELHI: India may also consider continued reviews for the Covid-19 vaccine, particularly the Oxford-AstraZeneca-developed candidate that is already under accelerated review by the UK health regulator, to further accelerate the approval of vaccines in the current pandemic situation. An ongoing review will allow the regulator to examine the data …
Read More »
Covishield, a vaccine candidate that has shown promise during trials, may be ready by December 2020, Serum Institute of India CEO Adar Poonawalla told News18. However, he added the caveat that “a lot is subject to UK data and also a lot depends on approvals from India’s Controller General of …
Read More »
The British national pharmaceuticals AstraZeneca vaccine to fight the novel coronavirus disease (Covid-19) has seen a robust immune response in older people, according to a report. The Financial Times report, citing two unidentified people familiar with the finding, said the vaccine the company is making has produced protective antibodies and …
Read More »
PARIS: Grim data highlighted the struggle by authorities around the world to control the coronavirus pandemic on Saturday, as the US reported 80,000 infections in a single day, France extended a curfew to two-thirds of citizens, and the death toll in Germany exceeded 10,000. The World Health Organization had previously …
Read More »
The Serum Institute of India (SII) is preparing 1 billion doses of five different vaccines against the coronavirus disease (Covid-19) worldwide before the end of 2021-22, according to a report. Adar Poonawalla, CEO of the world’s largest vaccine maker by volume, said his company plans to launch at least one …
Read More »
SAO PAULO / FRANFURT: Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the Covid-19 vaccine developed by AstraZeneca and the University of Oxford had passed away, but added that the trial would continue. Oxford confirmed the plan to continue testing, saying in a …
Read More »
In this illustration, taken on September 9, 2020, a test tube labeled with the vaccine is seen in front of the AstraZeneca logo. REUTERS / Dado Ruvic / Illustration The Federal University of Sao Paulo, which is helping coordinate phase 3 clinical trials in Brazil, said separately that the volunteer …
Read More »
An advanced-stage study of Johnson & Johnson’s (J&J) Covid-19 candidate vaccine was suspended Monday after it allegedly had an adverse effect on a participant. The participant’s “unexplained illness” is being investigated by the company and a statement was issued on Monday. Accidents and other so-called adverse events “are an expected …
Read More »
The UK National Health Service is preparing for mass vaccination (Representational) London: A coronavirus vaccine, jointly developed by scientists at the University of Oxford and the pharmaceutical giant AstraZeneca, may be approved by health regulators later this year, according to a report by UK media. The candidate vaccine is the …
Read More »
The mass launch of a Covid-19 vaccine in Britain could be completed in as little as three months, the Times reported, citing government scientists. Scientists working on the Oxford vaccine hope that regulators will approve it before early 2021, the newspaper said. A full Covid-19 immunization schedule, which would exclude …
Read More »